Description
Here are some of the uses of ATORVASTATIN (ATSTAT):
- Treatment of hypercholesterolemia
- Prevention of cardiovascular events
- Management of familial hypercholesterolemia
Sh3,500.00
ATORVASTATIN (ATSTAT) is a medication that belongs to the class of HMG-CoA reductase inhibitors or “statins”. It is used to lower cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke
Here are some of the uses of ATORVASTATIN (ATSTAT):
Settings | ATORVASTATIN 10MG ATSTAT remove | Atorvastatin 20mg Lipicure remove | AMBRODIL SYRP 100ml remove | AMBRODIL DROPS 15ML remove | Artequick Tablets remove | Ascard 75 Tablets remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh3,500.00 | Sh4,000.00 | Sh2,500.00 | Sh2,500.00 | Sh11,000.00 | Sh3,000.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | ATORVASTATIN (ATSTAT) is a medication that belongs to the class of HMG-CoA reductase inhibitors or "statins". It is used to lower cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke | |||||
Content | Here are some of the uses of ATORVASTATIN (ATSTAT):
| Lipicure 20 Tablet belongs to a group of medicines called statins. It is used to lower cholesterol and to reduce the risk of heart diseases. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, which may lead to a heart attack or stroke. | Used for treating
| It is used to treat
| Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury | Ascard belongs to the category of Anti-platelet and Anti-coagulant drugs. It prevents blood clots and helps the blood in flowing smoothly. It is primarily used for the prevention of cardiovascular diseases and to relieve muscle aches, toothaches, and headaches. |
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.